Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Bronchodilators on Exercise Capacity in Bronchiectasis
NCT05183841Enrolling by invitation
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Apr 2022
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ipratropium bromide and fenoterol in bronchiectasis (3 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoint: Endurance Time during Constant Load Exercise Test at Day 2. Started Apr 2022; status: enrolling by invitation.
02
Drugs
ipratropium bromidefenoterol
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT05183841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05183841.